Loading…
← CockpitCompetitor Analysis › 301371.SZ Harbin Fuerjia Technology Co., Ltd. Class AOpen in the cockpit ↗

Harbin Fuerjia Technology Co., Ltd. Class A301371.SZCompetitor analysis, valuation and peers

China · CNY·Consumer Staples›Household/Personal Care

Harbin-based household/personal-care products company; specific product lines not independently confirmed.

Momentum weak 30
Mkt cap
$1.51B
US dollars, full cap
Free float
70%
of shares outstanding
$/day
$7.03M
20-day average traded
Fwd P/E
21.4×
forward earnings
ROIC−WACC
+8.8 pp
WACC 9.8%
Hurdle
+4 pp
Req g minus delivered
Next earnings
156 days
23 Apr 2027
Close · CNYCN¥19.39
1D-2.2%
1W-4.4%
1M-4.3%
3M-23.1%
6M-39.3%
YTD-18.1%
1Y-21.9%
ATR %2.7%
52w lowhigh41.9% off high

What Harbin Fuerjia Technology does

Harbin-based household/personal-care products company; specific product lines not independently confirmed.

Where it sits in the supply chain

  • Consumer staples
  • Household/personal care

Moat: none

Headquarters: Harbin, China · Employees: 869

Harbin Fuerjia Technology at a glance

Size Harbin Fuerjia Technology (301371.SZ) is a China Consumer Staples company (Household/Personal Care) with a market value of $1.51B, the 1511th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥19.39 on 18 Nov 2026.

Performance Over six months the shares fell 39.3%, against +8.0% for the median peer and -20.0% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.

Growth Revenue grew 28.0% over the last twelve months (peer median +5.6%); the operating margin is 19.9% (peer median 9.9%).

Valuation It trades at 21.4× forward earnings against a peer median of 19.0× (9th most expensive of 21).

Price implies For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 8.8 points above its cost of capital (9.8% WACC).

Next results Next results expected around 23 Apr 2027 (exchange calendar; dates can move).

Relative performance

608010021 May 202621 Aug 202618 Nov 2026Peer median 109301371.SZ 60
Six months, rebased to 100: Harbin Fuerjia Technology against the median of its 20 peers (local-currency closes).

Harbin Fuerjia Technology financials

Reported figures in CNY; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueCN¥2.37BCN¥1.88BCN¥1.99BCN¥1.90BCN¥1.75B
Revenue growth—-6%+5%+9%—
Gross profitCN¥1.85BCN¥1.48BCN¥1.60BCN¥1.54BCN¥1.45B
EBITDAn/aCN¥488MCN¥803MCN¥942MCN¥1.01B
Net incomeCN¥470MCN¥433MCN¥661MCN¥749MCN¥847M
Free cash flowCN¥376MCN¥342MCN¥489MCN¥756MCN¥507M
Capital expenditureCN¥21.8MCN¥40.1MCN¥121MCN¥120MCN¥398M
Total debtCN¥14.2MCN¥6.95MCN¥11.1MCN¥8.15MCN¥912,785

Quarterly statements and history in the cockpit →

Harbin Fuerjia Technology competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-20%-10%0%+10%ICOS002790600315603983003006300957EPC79562145ENREMAMILTD4836504927161890699326984928PGHH301371.SZ6-month return →1-month return →
Up and to the right = strong over both horizons. Harbin Fuerjia Technology is the large dot.

Fundamentals: revenue growth against valuation

0%+20%+40%20×40×ICOS002790600315603983003006300957EPC79562145ENREMAMILTD48365049271618906993265726984928PGHH301371.SZRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Harbin Fuerjia Technology is the large dot.

Capital: growth delivered against growth the price implies

0%+20%+40%0%20%40%ICOS00279060031500300630095779562145ENREMAMILTD483650265726984928PGHH301371.SZGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Harbin Fuerjia Technology is the large dot.

Harbin Fuerjia Technology competitors and peer comparison

How Harbin Fuerjia Technology compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Harbin Fuerjia Technology against its 20 peers (data as of 18 Nov 2026)
Measure301371.SZPeer medianRank in peer set
1-month return-4.3%+2.2%7th lowest of 21
6-month return-39.3%+8.0%3rd lowest of 21
Distance from 52-week high-41.9%-24.2%5th lowest of 21
Revenue growth (TTM)+28.0%+5.6%3rd highest of 21
Operating margin19.9%9.9%6th highest of 21
Forward P/E21.4×19.0×9th most expensive of 21
Growth the price implies (Req g, 7 yrs)7.5%0.5%7th most demanding of 17
Growth delivered (Del g)+3.6%+9.5%6th lowest of 17
Hurdle (Req g minus delivered)+3.8 pp-5.9 pp5th most demanding of 17
ROIC minus cost of capital+8.8 pp+6.2 pp8th highest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Harbin Fuerjia Technology 301371.SZChina$1.51B-39%+28%20%21.4×7.5%+3.6%
Intercos ICOS.MIItaly$1.43B+12%-5%9%18.9×4.3%+11.5%
AMOREPACIFIC 002790.KSSouth Korea$1.61B+2%+9%9%8.5×-5.7%-1.3%
Shanghai Jahwa United 600315.SSChina$1.61B-15%+9%2%15.4×15.3%-2.1%
Guangdong Marubi Biotechnology 603983.SSChina$1.62B+9%-6%2%45.5×n/an/a
Chongqing Baiya Sanitary Products 003006.SZChina$1.35B+27%0%3%37.3×28.8%+22.8%
Yunnan Botanee Bio-Technology 300957.SZChina$1.69B-33%+7%9%19.1×2.6%+15.3%
Edgewell Personal Care EPCUnited States$1.30B+67%-10%7%14.2×n/an/a
Pigeon 7956.TJapan$1.76B+26%+8%13%27.9×-2.4%+1.9%
Shanghai Chicmax Cosmetics 2145.HKHong Kong$1.17B-42%+23%8%14.4×-6.1%+21.2%
Energizer ENRUnited States$1.94B+71%0%17%9.1×-5.1%-0.5%
Emami EMAMILTD.NSIndia$1.94B-5%+13%20%23.4×21.5%+5.6%
d'Alba Global 483650.KSSouth Korea$1.13B-55%+49%22%12.0×-6.6%+53.0%
Pola Orbis 4927.TJapan$2.04B+15%+1%11%30.6×-2.0%-0.7%
Kolmar Korea 161890.KSSouth Korea$2.05B+14%+16%10%14.3×-1.6%+15.5%
Blue Moon 6993.HKHong Kong$2.07B-4%-2%-2%103.3×n/an/a
KOSE 4922.TJapan$2.16B+16%+4%5%29.9×n/an/a
Shanghai Forest Cabin Cosmetics 2657.HKHong Kong$1.04B+15%+74%18%11.8×11.3%+49.0%
Softcare 2698.HKHong Kong$2.20B+5%+25%25%14.4×9.1%+20.9%
Noevir 4928.TJapan$978M+7%-3%28%20.4×-12.8%+4.1%
Procter & Gamble Hygiene & Health Care PGHH.NSIndia$2.37B-30%-2%24%27.0×21.2%+7.4%

Questions

Which companies are Harbin Fuerjia Technology's closest peers?
The cockpit's peer set: Intercos (ICOS.MI), AMOREPACIFIC (002790.KS), Shanghai Jahwa United (600315.SS), Guangdong Marubi Biotechnology (603983.SS), Chongqing Baiya Sanitary Products (003006.SZ), Yunnan Botanee Bio-Technology (300957.SZ), Edgewell Personal Care (EPC), Pigeon (7956.T).
Is Harbin Fuerjia Technology expensive compared with its peers?
On forward p/e it trades at 21.4× against a peer median of 19.0×, 9th most expensive of 21 in its peer set. For today's price to make sense, revenue must grow about 7% a year for seven years (Req g). Recent delivered growth is +4%, so the hurdle is +4 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Harbin Fuerjia Technology stock performed?
Over six months to 18 Nov 2026 the shares returned -39.3% against +8.0% for the median peer; over one year -21.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.